“Essential” Markets, Public Health, and Private Learning
“Essential” Markets, Public Health, and Private Learning
This chapter examines the private sector-led market environment for the pharmaceutical industry in India. It describes how government was able to create private sector capability in core public health areas through the strategic use of essential drug categories. This chapter also argues that contrary to popular belief, the Indian supply-side capabilities were built entirely from its process patent regime and explains how the regulatory structures helped establish the specific markets in which technological learning led to the eventual dominance of the domestic market by Indian private firms.
Keywords: pharmaceutical industry, private sector, India, essential drug categories, public health, supply-side capabilities, patent regime, private firms
Stanford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
Please, subscribe or login to access full text content.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us.
